Action Point Financial Planning’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1
Closed -$18 – 2242
2026
Q2
$18 Buy
+1
New +$19 ﹤0.01% 2775

Other funds holding SRPT

Action Point Financial Planning's SRPT Position: Q3 2026 in Review

Action Point Financial Planning sold out of Sarepta Therapeutics (SRPT) in Q3 2026, closing a stake of 1 share — an estimated $18 sold.

Action Point Financial Planning first reported a position in SRPT in Q2 2026 and held it in 1 quarter. The position peaked at $18 in Q2 2026. 305 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.

  • Action Point Financial Planning reported no remaining Sarepta Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 1 Sarepta Therapeutics share in Q3 2026, an estimated $18.
  • Action Point Financial Planning first reported a position in Sarepta Therapeutics in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Sarepta Therapeutics position peaked at $18 in Q2 2026.
  • 305 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.